Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Arbor Pharmaceuticals Inc.
EIR
•Arbor Pharmaceuticals Inc.•October 15, 2021

Arbor Pharmaceuticals Inc. – FDA EIR, Oct 15, 2021

Record Details

The FDA conducted a comprehensive postmarketing adverse drug experience (PADE) inspection of Arbor Pharmaceuticals Inc. from October 12-15, 2021, at its Atlanta, GA location. This surveillance inspection, requested by the Center for Drug Evaluation and Research (CDER) under Compliance Program 7353.001, focused on the firm's procedures for monitoring, receiving, processing, and submitting adverse events for products regulated under the Food, Drug, and Cosmetic Act. While no official FDA Form 483 (Inspectional Observations) was issued, three important discussion items were communicated to management. These included the need for Standard Operating Procedures (SOPs) to accurately reflect current processes, ensuring expedited adverse events are submitted within the required 15-day timeline (19 late submissions were identified over three years), and ensuring timely submission of periodic safety reports (one quarterly report was 35 days late). Arbor Pharmaceuticals management acknowledged these observations and demonstrated cooperation. As a corrective action, updated SOPs were provided during the inspection to better align with current procedures, and a corrective action plan was in place for the late periodic safety report. The final inspection classification will be determined by CDER.

Company
Arbor Pharmaceuticals Inc.
Inspection date
October 15, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Evan Scullin (company_representative)
  • Thomas A. Rowland (recipient)
  • Tina L. Morton (company_representative)
  • Allison Lowry
  • Philisha Mack (company_representative)
View Company Profile

ID · 8a4f9c08-65c5-44c7-9fe5-a6f56ec809d3

Other documents for Arbor Pharmaceuticals Inc.
  • EIR - 2016-01-28January 28, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Arbor Pharmaceuticals Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.